IL290961A - System and method of multi-drug delivery - Google Patents
System and method of multi-drug deliveryInfo
- Publication number
- IL290961A IL290961A IL290961A IL29096122A IL290961A IL 290961 A IL290961 A IL 290961A IL 290961 A IL290961 A IL 290961A IL 29096122 A IL29096122 A IL 29096122A IL 290961 A IL290961 A IL 290961A
- Authority
- IL
- Israel
- Prior art keywords
- drug delivery
- drug
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962893567P | 2019-08-29 | 2019-08-29 | |
US201962893573P | 2019-08-29 | 2019-08-29 | |
US202062981180P | 2020-02-25 | 2020-02-25 | |
US202063022823P | 2020-05-11 | 2020-05-11 | |
PCT/US2020/048107 WO2021041608A1 (en) | 2019-08-29 | 2020-08-27 | System and method of multi-drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
IL290961A true IL290961A (en) | 2022-04-01 |
Family
ID=74683538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL290961A IL290961A (en) | 2019-08-29 | 2022-02-27 | System and method of multi-drug delivery |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP4021420A4 (en) |
JP (1) | JP2022546496A (en) |
CN (1) | CN114650810A (en) |
AU (1) | AU2020336093A1 (en) |
BR (1) | BR112022003895A2 (en) |
CA (1) | CA3152734A1 (en) |
IL (1) | IL290961A (en) |
MX (1) | MX2022002526A (en) |
WO (1) | WO2021041608A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115989023A (en) * | 2020-08-25 | 2023-04-18 | 艾伯维公司 | System and method for multiple drug delivery |
US11273128B1 (en) * | 2021-04-15 | 2022-03-15 | Sandoz Ag | Elagolix formulation |
CN116648239A (en) * | 2021-08-26 | 2023-08-25 | 宁德时代新能源科技股份有限公司 | Liquid bag, battery monomer, battery and electricity utilization device |
CN113876728B (en) * | 2021-11-17 | 2022-12-13 | 南京唯创远医药科技有限公司 | Oxagolide freeze-dried tablet and preparation method thereof |
EP4279075B1 (en) * | 2022-05-12 | 2024-07-10 | Zaklady Farmaceutyczne Polpharma S.A. | A pharmaceutical composition comprising elagolix |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
US20080075772A1 (en) * | 2006-04-13 | 2008-03-27 | Lawrence Solomon | Pharmaceutical compositions having novel scoring patterns and methods of using those compositions |
WO2010014502A1 (en) * | 2008-07-31 | 2010-02-04 | Aptapharma, Inc. | Functionally coated breakable tablets |
KR101861307B1 (en) * | 2011-10-13 | 2018-07-06 | 한미약품 주식회사 | Composite formulation comprising a tablet encapsulated in a hard capsule |
EP3384930A1 (en) * | 2013-03-15 | 2018-10-10 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
US9456987B2 (en) * | 2013-04-03 | 2016-10-04 | Binutra, Inc. | Capsule with internal diaphragm |
AU2017316583A1 (en) * | 2016-08-23 | 2019-03-28 | Mylan Inc. | Child resistant medication packaging |
TW201912157A (en) * | 2017-08-18 | 2019-04-01 | 美商艾伯維有限公司 | Solid pharmaceutical formulation for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis |
-
2020
- 2020-08-27 CN CN202080074708.5A patent/CN114650810A/en active Pending
- 2020-08-27 JP JP2022513623A patent/JP2022546496A/en active Pending
- 2020-08-27 MX MX2022002526A patent/MX2022002526A/en unknown
- 2020-08-27 EP EP20857394.9A patent/EP4021420A4/en active Pending
- 2020-08-27 AU AU2020336093A patent/AU2020336093A1/en not_active Abandoned
- 2020-08-27 CA CA3152734A patent/CA3152734A1/en active Pending
- 2020-08-27 WO PCT/US2020/048107 patent/WO2021041608A1/en active Application Filing
- 2020-08-27 BR BR112022003895A patent/BR112022003895A2/en unknown
-
2022
- 2022-02-27 IL IL290961A patent/IL290961A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP4021420A1 (en) | 2022-07-06 |
WO2021041608A1 (en) | 2021-03-04 |
CA3152734A1 (en) | 2021-03-04 |
BR112022003895A2 (en) | 2022-05-24 |
MX2022002526A (en) | 2022-06-23 |
JP2022546496A (en) | 2022-11-04 |
CN114650810A (en) | 2022-06-21 |
EP4021420A4 (en) | 2023-11-22 |
AU2020336093A1 (en) | 2022-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290961A (en) | System and method of multi-drug delivery | |
IL264677B (en) | System and method for continuous testing and delivery of software | |
EP3384125A4 (en) | Method and apparatus for elevating the tapered stress joint or flex joint of an scr above the water | |
EP3666849A4 (en) | Diverting agent and method using same for filling crack of winze | |
EP3838804A4 (en) | Delivery site and delivery method | |
EP3820403A4 (en) | Implant delivery system and method | |
EP3820411A4 (en) | Implant delivery system and method of use | |
GB2596770B (en) | Carrier-resolved photo-hall system and method | |
GB201906418D0 (en) | Conveyor system and method | |
SG11202103826SA (en) | Method of secure communication and system thereof | |
GB2573856B (en) | Dispenser system and method of use | |
IL284565A (en) | Transdermal system for the delivery of abaloparatide and method of use | |
SG10202010783RA (en) | Restoration coating system and method | |
EP3908708A4 (en) | Bioretentional system and method of construction thereof | |
GB2600580B (en) | System and method for preparing MRNA | |
GB202115550D0 (en) | System and method for management of substances | |
GB2590126B (en) | Navigation system and method | |
SG11202108415YA (en) | Direct extended reach system and method | |
EP4062126C0 (en) | Navigation system and method | |
EP3805067A4 (en) | Yunitsky transport system and method of construction thereof | |
GB201914948D0 (en) | System and method of aerosol delivery | |
GB201914952D0 (en) | System and method of aerosol delivery | |
GB2602592B (en) | Design system and design method | |
GB201900467D0 (en) | Dispenser system and method of use | |
EP3861356A4 (en) | System and method of fluid delivery |